Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
2.
Cell Rep ; 42(11): 113384, 2023 11 28.
Article in English | MEDLINE | ID: mdl-37934666

ABSTRACT

Deletion of the obsessive-compulsive disorder (OCD)-associated gene SAP90/PSD-95-associated protein 3 (Sapap3), which encodes a postsynaptic anchoring protein at corticostriatal synapses, causes OCD-like motor behaviors in mice. While corticostriatal synaptic dysfunction is central to this phenotype, the striatum efficiently adapts to pathological changes, often in ways that expand upon the original circuit impairment. Here, we show that SAPAP3 deletion causes non-synaptic and pathway-specific alterations in dorsolateral striatum circuit function. While somatic excitability was elevated in striatal projection neurons (SPNs), dendritic excitability was exclusively enhanced in direct pathway SPNs. Layered on top of this, cholinergic modulation was altered in opposing ways: striatal cholinergic interneuron density and evoked acetylcholine release were elevated, while basal muscarinic modulation of SPNs was reduced. These data describe how SAPAP3 deletion alters the striatal landscape upon which impaired corticostriatal inputs will act, offering a basis for how pathological synaptic integration and unbalanced striatal output underlying OCD-like behaviors may be shaped.


Subject(s)
Nerve Tissue Proteins , Obsessive-Compulsive Disorder , Mice , Animals , Nerve Tissue Proteins/metabolism , Corpus Striatum/metabolism , Neostriatum/metabolism , Obsessive-Compulsive Disorder/genetics , Cholinergic Agents/metabolism
3.
Nat Commun ; 13(1): 5942, 2022 10 08.
Article in English | MEDLINE | ID: mdl-36209150

ABSTRACT

The auditory striatum, the tail portion of dorsal striatum in basal ganglia, is implicated in perceptual decision-making, transforming auditory stimuli to action outcomes. Despite its known connections to diverse neurological conditions, the dopaminergic modulation of sensory striatal neuronal activity and its behavioral influences remain unknown. We demonstrated that the optogenetic inhibition of dopaminergic projections from the substantia nigra pars compacta to the auditory striatum specifically impairs mouse choice performance but not movement in an auditory frequency discrimination task. In vivo dopamine and calcium imaging in freely behaving mice revealed that this dopaminergic projection modulates striatal tone representations, and tone-evoked striatal dopamine release inversely correlated with the evidence strength of tones. Optogenetic inhibition of D1-receptor expressing neurons and pharmacological inhibition of D1 receptors in the auditory striatum dampened choice performance accuracy. Our study uncovers a phasic mechanism within the nigrostriatal system that regulates auditory decisions by modulating ongoing auditory perception.


Subject(s)
Dopamine , Substantia Nigra , Animals , Auditory Perception , Calcium/metabolism , Corpus Striatum/physiology , Dopamine/metabolism , Mice , Receptors, Dopamine D1/metabolism , Substantia Nigra/metabolism
4.
Elife ; 112022 05 17.
Article in English | MEDLINE | ID: mdl-35579422

ABSTRACT

Striatal spiny projection neurons (SPNs) transform convergent excitatory corticostriatal inputs into an inhibitory signal that shapes basal ganglia output. This process is fine-tuned by striatal GABAergic interneurons (GINs), which receive overlapping cortical inputs and mediate rapid corticostriatal feedforward inhibition of SPNs. Adding another level of control, cholinergic interneurons (CINs), which are also vigorously activated by corticostriatal excitation, can disynaptically inhibit SPNs by activating α4ß2 nicotinic acetylcholine receptors (nAChRs) on various GINs. Measurements of this disynaptic inhibitory pathway, however, indicate that it is too slow to compete with direct GIN-mediated feedforward inhibition. Moreover, functional nAChRs are also present on populations of GINs that respond only weakly to phasic activation of CINs, such as parvalbumin-positive fast-spiking interneurons (PV-FSIs), making the overall role of nAChRs in shaping striatal synaptic integration unclear. Using acute striatal slices from mice we show that upon synchronous optogenetic activation of corticostriatal projections blockade of α4ß2 nAChRs shortened SPN spike latencies and increased postsynaptic depolarizations. The nAChR-dependent inhibition was mediated by downstream GABA release, and data suggest that the GABA source was not limited to GINs that respond strongly to phasic CIN activation. In particular, the observed decrease in spike latency caused by nAChR blockade was associated with a diminished frequency of spontaneous inhibitory postsynaptic currents in SPNs, a parallel hyperpolarization of PV-FSIs, and was occluded by pharmacologically preventing cortical activation of PV-FSIs. Taken together, we describe a role for tonic (as opposed to phasic) activation of nAChRs in striatal function. We conclude that tonic activation of nAChRs by CINs maintains a GABAergic brake on cortically-driven striatal output by 'priming' feedforward inhibition, a process that may shape SPN spike timing, striatal processing, and synaptic plasticity.


Subject(s)
Corpus Striatum , Nicotine , Animals , Cholinergic Agents/metabolism , Corpus Striatum/physiology , Interneurons/physiology , Mice , Neurons/metabolism , Nicotine/metabolism , gamma-Aminobutyric Acid/metabolism
5.
Neuron ; 108(6): 1091-1102.e5, 2020 12 23.
Article in English | MEDLINE | ID: mdl-33080228

ABSTRACT

Corticostriatal synaptic integration is partitioned among striosome (patch) and matrix compartments of the dorsal striatum, allowing compartmentalized control of discrete aspects of behavior. Despite the significance of such organization, it's unclear how compartment-specific striatal output is dynamically achieved, particularly considering new evidence that overlap of afferents is substantial. We show that dopamine oppositely shapes responses to convergent excitatory inputs in mouse striosome and matrix striatal spiny projection neurons (SPNs). Activation of postsynaptic D1 dopamine receptors promoted the generation of long-lasting synaptically evoked "up-states" in matrix SPNs but opposed it in striosomes, which were more excitable under basal conditions. Differences in dopaminergic modulation were mediated, in part, by dendritic voltage-gated calcium channels (VGCCs): pharmacological manipulation of L-type VGCCs reversed compartment-specific responses to D1 receptor activation. These results support a novel mechanism for the selection of striatal circuit components, where fluctuating levels of dopamine shift the balance of compartment-specific striatal output.


Subject(s)
Corpus Striatum/drug effects , Dendrites/drug effects , Neurons/drug effects , Receptors, Dopamine D1/antagonists & inhibitors , Animals , Benzazepines/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/metabolism , Corpus Striatum/metabolism , Dendrites/metabolism , Dopamine Antagonists/pharmacology , Isradipine/pharmacology , Mice , Mice, Transgenic , Neurons/metabolism , Receptors, Dopamine D1/metabolism , Synapses/drug effects , Synapses/metabolism
6.
eNeuro ; 6(5)2019.
Article in English | MEDLINE | ID: mdl-31541002

ABSTRACT

The GABAergic medium-size spiny neuron (MSN), the striatal output neuron, may be classified into striosome, also known as patch, and matrix, based on neurochemical differences between the two compartments. At this time, little is known regarding the regulation of the development of the two compartments. Nr4a1, primarily described as a nuclear receptor/immediate early gene involved in the homeostasis of the dopaminergic system, is a striosomal marker. Using Nr4a1-overexpressing and Nr4a1-null mice, we sought to determine whether Nr4a1 is necessary and/or sufficient for striosome development. We report that in vivo and in vitro, Nr4a1 and Oprm1 mRNA levels are correlated. In the absence of Nr4a, there is a decrease in the percentage of striatal surface area occupied by striosomes. Alterations in Nr4a1 expression leads to dysregulation of multiple mRNAs of members of the dopamine receptor D1 signal transduction system. Constitutive overexpression of Nr4a1 decreases both the induction of phosphorylation of ERK after a single cocaine exposure and locomotor sensitization following chronic cocaine exposure. Nr4a1 overexpression increases MSN excitability but reduces MSN long-term potentiation. In the resting state, type 5 adenylyl cyclase (AC5) activity is normal, but the ability of AC5 to be activated by Drd1 G-protein-coupled receptor inputs is decreased. Our results support a role for Nr4a1 in determination of striatal patch/matrix structure and in regulation of dopaminoceptive neuronal function.


Subject(s)
Corpus Striatum/metabolism , Neurons/metabolism , Nuclear Receptor Subfamily 4, Group A, Member 1/biosynthesis , Receptors, Dopamine D1/biosynthesis , Signal Transduction/physiology , Animals , Animals, Newborn , Cells, Cultured , Cocaine/pharmacology , Corpus Striatum/cytology , Corpus Striatum/drug effects , Dopamine Uptake Inhibitors/pharmacology , Humans , Locomotion/drug effects , Locomotion/physiology , Male , Mice , Mice, Knockout , Mice, Transgenic , Neurons/drug effects , Nuclear Receptor Subfamily 4, Group A, Member 1/deficiency , Signal Transduction/drug effects
7.
J Neurosci Res ; 97(12): 1503-1514, 2019 12.
Article in English | MEDLINE | ID: mdl-31489687

ABSTRACT

The striatum plays a central role in guiding numerous complex behaviors, ranging from motor control to action selection and reward learning. The diverse responsibilities of the striatum are reflected by the complexity of its organization. In this review, we will summarize what is currently known about the compartmental layout of the striatum, an organizational principle that is crucial for allowing the striatum to guide such a diverse array of behaviors. We will focus on the anatomical and functional properties of striosome (patch) and matrix compartments of the striatum, and how the engagement of these compartments is uniquely controlled by their afferents, intrinsic properties, and neuromodulation. We will give examples of how advances in technology have opened the door to functionally dissecting the striatum's compartmental design, and close by offering thoughts on the future and relevance for human disease.


Subject(s)
Corpus Striatum/physiology , Neurons/physiology , Acetylcholine/physiology , Animals , Brain/physiology , Dopamine/physiology , Glutamic Acid/physiology , Humans , Models, Neurological , Neural Pathways/physiology , Receptors, Opioid, mu/physiology , Substance P/physiology , Synapses/physiology , gamma-Aminobutyric Acid/physiology
8.
Elife ; 82019 04 24.
Article in English | MEDLINE | ID: mdl-31017573

ABSTRACT

Huntington's disease (HD) is initially characterized by an inability to suppress unwanted movements, a deficit attributable to impaired synaptic activation of striatal indirect pathway spiny projection neurons (iSPNs). To better understand the mechanisms underlying this deficit, striatal neurons in ex vivo brain slices from mouse genetic models of HD were studied using electrophysiological, optical and biochemical approaches. Distal dendrites of iSPNs from symptomatic HD mice were hypoexcitable, a change that was attributable to increased association of dendritic Kv4 potassium channels with auxiliary KChIP subunits. This association was negatively modulated by TrkB receptor signaling. Dendritic excitability of HD iSPNs was rescued by knocking-down expression of Kv4 channels, by disrupting KChIP binding, by restoring TrkB receptor signaling or by lowering mutant-Htt (mHtt) levels with a zinc finger protein. Collectively, these studies demonstrate that mHtt induces reversible alterations in the dendritic excitability of iSPNs that could contribute to the motor symptoms of HD.


Subject(s)
Corpus Striatum/pathology , Huntingtin Protein/metabolism , Huntington Disease/pathology , Huntington Disease/physiopathology , Mutant Proteins/metabolism , Neurons/metabolism , Shal Potassium Channels/metabolism , Animals , Disease Models, Animal , Huntingtin Protein/genetics , Mice , Mutant Proteins/genetics
9.
Cancer Rep (Hoboken) ; 2(1): e1150, 2019 02.
Article in English | MEDLINE | ID: mdl-32721132

ABSTRACT

Progress in basic and clinical research is slowed when researchers fail to provide a complete and accurate report of how a study was designed, executed, and the results analyzed. Publishing rigorous scientific research involves a full description of the methods, materials, procedures, and outcomes. Investigators may fail to provide a complete description of how their study was designed and executed because they may not know how to accurately report the information or the mechanisms are not in place to facilitate transparent reporting. Here, we provide an overview of how authors can write manuscripts in a transparent and thorough manner. We introduce a set of reporting criteria that can be used for publishing, including recommendations on reporting the experimental design and statistical approaches. We also discuss how to accurately visualize the results and provide recommendations for peer reviewers to enhance rigor and transparency. Incorporating transparency practices into research manuscripts will significantly improve the reproducibility of the results by independent laboratories. SIGNIFICANCE: Failure to replicate research findings often arises from errors in the experimental design and statistical approaches. By providing a full account of the experimental design, procedures, and statistical approaches, researchers can address the reproducibility crisis and improve the sustainability of research outcomes. In this piece, we discuss the key issues leading to irreproducibility and provide general approaches to improving transparency and rigor in reporting, which could assist in making research more reproducible.


Subject(s)
Biomedical Research/statistics & numerical data , Peer Review, Research/methods , Publishing/standards , Quality Improvement/standards , Research Design/standards , Research Personnel/standards , Data Accuracy , Editorial Policies , Humans , Reproducibility of Results
10.
Neuroscientist ; 25(4): 359-379, 2019 08.
Article in English | MEDLINE | ID: mdl-30379121

ABSTRACT

The basal ganglia are an intricately connected assembly of subcortical nuclei, forming the core of an adaptive network connecting cortical and thalamic circuits. For nearly three decades, researchers and medical practitioners have conceptualized how the basal ganglia circuit works, and how its pathology underlies motor disorders such as Parkinson's and Huntington's diseases, using what is often referred to as the "box-and-arrow model": a circuit diagram showing the broad strokes of basal ganglia connectivity and the pathological increases and decreases in the weights of specific connections that occur in disease. While this model still has great utility and has led to groundbreaking strategies to treat motor disorders, our evolving knowledge of basal ganglia function has made it clear that this classic model has several shortcomings that severely limit its predictive and descriptive abilities. In this review, we will focus on the striatum, the main input nucleus of the basal ganglia. We describe recent advances in our understanding of the rich microcircuitry and plastic capabilities of the striatum, factors not captured by the original box-and-arrow model, and provide examples of how such advances inform our current understanding of the circuit pathologies underlying motor disorders.


Subject(s)
Basal Ganglia/physiopathology , Interneurons/physiology , Models, Neurological , Movement Disorders/physiopathology , Acetylcholine/physiology , Animals , Corpus Striatum/physiopathology , Dopamine/physiology , GABAergic Neurons/physiology , Humans , Neural Pathways/physiopathology , Neuronal Plasticity/physiology
11.
J Neurosci Res ; 97(4): 377-390, 2019 04.
Article in English | MEDLINE | ID: mdl-30506706

ABSTRACT

Progress in basic and clinical research is slowed when researchers fail to provide a complete and accurate report of how a study was designed, executed, and the results analyzed. Publishing rigorous scientific research involves a full description of the methods, materials, procedures, and outcomes. Investigators may fail to provide a complete description of how their study was designed and executed because they may not know how to accurately report the information or the mechanisms are not in place to facilitate transparent reporting. Here, we provide an overview of how authors can write manuscripts in a transparent and thorough manner. We introduce a set of reporting criteria that can be used for publishing, including recommendations on reporting the experimental design and statistical approaches. We also discuss how to accurately visualize the results and provide recommendations for peer reviewers to enhance rigor and transparency. Incorporating transparency practices into research manuscripts will significantly improve the reproducibility of the results by independent laboratories.


Subject(s)
Biomedical Research/standards , Publishing/standards , Data Accuracy , Humans , Quality Improvement , Reproducibility of Results , Research Design/standards
12.
Brain Behav ; 9(1): e01141, 2019 01.
Article in English | MEDLINE | ID: mdl-30506879

ABSTRACT

Progress in basic and clinical research is slowed when researchers fail to provide a complete and accurate report of how a study was designed, executed, and the results analyzed. Publishing rigorous scientific research involves a full description of the methods, materials, procedures, and outcomes. Investigators may fail to provide a complete description of how their study was designed and executed because they may not know how to accurately report the information or the mechanisms are not in place to facilitate transparent reporting. Here, we provide an overview of how authors can write manuscripts in a transparent and thorough manner. We introduce a set of reporting criteria that can be used for publishing, including recommendations on reporting the experimental design and statistical approaches. We also discuss how to accurately visualize the results and provide recommendations for peer reviewers to enhance rigor and transparency. Incorporating transparency practices into research manuscripts will significantly improve the reproducibility of the results by independent laboratories.


Subject(s)
Biomedical Research/methods , Publishing/standards , Research Design/standards , Data Accuracy , Humans , Quality Improvement , Reproducibility of Results
15.
Cell Rep ; 13(7): 1336-1342, 2015 Nov 17.
Article in English | MEDLINE | ID: mdl-26549446

ABSTRACT

Experience-driven plasticity of glutamatergic synapses on striatal spiny projection neurons (SPNs) is thought to be essential to goal-directed behavior and habit formation. One major form of striatal plasticity, long-term depression (LTD), has long appeared to be expressed only pre-synaptically. Contrary to this view, nitric oxide (NO) generated by striatal interneurons was found to induce a post-synaptically expressed form of LTD at SPN glutamatergic synapses. This form of LTD was dependent on signaling through guanylyl cyclase and protein kinase G, both of which are abundantly expressed by SPNs. NO-LTD was unaffected by local synaptic activity or antagonism of endocannabinoid (eCb) and dopamine receptors, all of which modulate canonical, pre-synaptic LTD. Moreover, NO signaling disrupted induction of this canonical LTD by inhibiting dendritic Ca(2+) channels regulating eCb synthesis. These results establish an interneuron-dependent, heterosynaptic form of post-synaptic LTD that could act to promote stability of the striatal network during learning.


Subject(s)
Interneurons/physiology , Long-Term Synaptic Depression , Nitric Oxide/physiology , Animals , Excitatory Postsynaptic Potentials , Glutamic Acid/physiology , Mice , Optogenetics , Synapses
16.
Neuron ; 88(4): 762-73, 2015 Nov 18.
Article in English | MEDLINE | ID: mdl-26590347

ABSTRACT

A balanced interaction between dopaminergic and cholinergic signaling in the striatum is critical to goal-directed behavior. But how this interaction modulates corticostriatal synaptic plasticity underlying learned actions remains unclear--particularly in direct-pathway spiny projection neurons (dSPNs). Our studies show that in dSPNs, endogenous cholinergic signaling through M4 muscarinic receptors (M4Rs) promoted long-term depression of corticostriatal glutamatergic synapses, by suppressing regulator of G protein signaling type 4 (RGS4) activity, and blocked D1 dopamine receptor dependent long-term potentiation (LTP). Furthermore, in a mouse model of L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia (LID) in Parkinson's disease (PD), boosting M4R signaling with positive allosteric modulator (PAM) blocked aberrant LTP in dSPNs, enabled LTP reversal, and attenuated dyskinetic behaviors. An M4R PAM also was effective in a primate LID model. Taken together, these studies identify an important signaling pathway controlling striatal synaptic plasticity and point to a novel pharmacological strategy for alleviating LID in PD patients.


Subject(s)
Dopamine Agents/toxicity , Dyskinesia, Drug-Induced/metabolism , Levodopa/toxicity , Neostriatum/drug effects , Neuronal Plasticity/drug effects , Parkinsonian Disorders/drug therapy , RGS Proteins/metabolism , Receptor, Muscarinic M4/metabolism , Allosteric Regulation , Animals , Cerebral Cortex/metabolism , Disease Models, Animal , Dyskinesia, Drug-Induced/etiology , Glutamic Acid , Long-Term Potentiation/drug effects , Long-Term Synaptic Depression/drug effects , Macaca mulatta , Mice , Mice, Transgenic , Neostriatum/metabolism , Neurons , Signal Transduction
17.
Curr Opin Neurobiol ; 33: 53-62, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25700146

ABSTRACT

Huntington's disease (HD) is a progressive neurodegenerative disorder that profoundly impairs corticostriatal information processing. While late stage pathology includes cell death, the appearance of motor symptoms parallels more subtle changes in neuronal function and synaptic integration. Because of the difficulty in modeling the disease and the complexity of the corticostriatal network, understanding the mechanisms driving pathology has been slow to develop. In recent years, advances in animal models and network analysis tools have begun to shed light on the circuit-specific deficits. These studies have revealed a progressive impairment of corticostriatal synaptic signaling in subpopulations of striatal neurons, turning classical excitotoxicity models of HD upside down. Disrupted brain derived neurotrophic factor signaling appears to be a key factor in this decline.


Subject(s)
Adaptation, Physiological/physiology , Cerebral Cortex/physiopathology , Corpus Striatum/physiopathology , Huntington Disease/pathology , Synapses/physiology , Animals , Brain-Derived Neurotrophic Factor/deficiency , Brain-Derived Neurotrophic Factor/genetics , Humans , Huntington Disease/genetics , Huntington Disease/physiopathology , Mice , Mice, Knockout
18.
Nat Commun ; 5: 5316, 2014 Oct 31.
Article in English | MEDLINE | ID: mdl-25360704

ABSTRACT

The striatum is widely viewed as the fulcrum of pathophysiology in Parkinson's disease (PD) and L-DOPA-induced dyskinesia (LID). In these disease states, the balance in activity of striatal direct pathway spiny projection neurons (dSPNs) and indirect pathway spiny projection neurons (iSPNs) is disrupted, leading to aberrant action selection. However, it is unclear whether countervailing mechanisms are engaged in these states. Here we report that iSPN intrinsic excitability and excitatory corticostriatal synaptic connectivity were lower in PD models than normal; L-DOPA treatment restored these properties. Conversely, dSPN intrinsic excitability was elevated in tissue from PD models and suppressed in LID models. Although the synaptic connectivity of dSPNs did not change in PD models, it fell with L-DOPA treatment. In neither case, however, was the strength of corticostriatal connections globally scaled. Thus, SPNs manifested homeostatic adaptations in intrinsic excitability and in the number but not strength of excitatory corticostriatal synapses.


Subject(s)
Corpus Striatum/physiopathology , Dopaminergic Neurons/physiology , Dyskinesia, Drug-Induced/physiopathology , Neuronal Plasticity , Parkinsonian Disorders/physiopathology , Animals , Dendritic Spines/pathology , Disease Models, Animal , Dyskinesia, Drug-Induced/metabolism , In Vitro Techniques , Male , Mice, Inbred C57BL , Parkinsonian Disorders/pathology , Receptors, AMPA/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism
19.
Neuron ; 83(1): 178-88, 2014 Jul 02.
Article in English | MEDLINE | ID: mdl-24991961

ABSTRACT

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. The debilitating choreic movements that plague HD patients have been attributed to striatal degeneration induced by the loss of cortically supplied brain-derived neurotrophic factor (BDNF). Here, we show that in mouse models of early symptomatic HD, BDNF delivery to the striatum and its activation of tyrosine-related kinase B (TrkB) receptors were normal. However, in striatal neurons responsible for movement suppression, TrkB receptors failed to properly engage postsynaptic signaling mechanisms controlling the induction of potentiation at corticostriatal synapses. Plasticity was rescued by inhibiting p75 neurotrophin receptor (p75NTR) signaling or its downstream target phosphatase-and-tensin-homolog-deleted-on-chromosome-10 (PTEN). Thus, corticostriatal synaptic dysfunction early in HD is attributable to a correctable defect in the response to BDNF, not its delivery.


Subject(s)
Cerebral Cortex/physiopathology , Corpus Striatum/physiopathology , Disease Models, Animal , Huntington Disease/physiopathology , Receptor, trkB/deficiency , Signal Transduction/genetics , Animals , Cerebral Cortex/pathology , Corpus Striatum/pathology , Gene Knock-In Techniques , Huntington Disease/genetics , Huntington Disease/pathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Organ Culture Techniques , Receptor, trkB/antagonists & inhibitors , Receptor, trkB/physiology
20.
Methods Mol Biol ; 1183: 171-82, 2014.
Article in English | MEDLINE | ID: mdl-25023308

ABSTRACT

As the main input nucleus to the basal ganglia, the striatum is responsible for receiving and integrating highly convergent afferents to ultimately guide action selection and movement initiation. Although the majority of this synaptic integration occurs in the dendrites of striatal projection neurons (SPNs), their thin diameter makes them inaccessible with traditional recording electrodes. Recent advances in optical imaging technologies have allowed us and others to start lifting the veil on the mechanisms governing synaptic integration in the striatum by enabling direct dendritic measurements and manipulations. Here we describe how our lab has approached combining 2-photon imaging and photolysis with electrophysiological recordings to study dendritic excitability and synaptic integration in the striatum.


Subject(s)
Corpus Striatum/physiology , Dendrites/physiology , Optical Imaging/methods , Patch-Clamp Techniques/methods , Synapses/physiology , Animals , Calcium/analysis , Calcium/metabolism , Dendrites/ultrastructure , Electrophysiology/instrumentation , Electrophysiology/methods , Equipment Design , Glutamic Acid/analysis , Glutamic Acid/metabolism , Humans , Lasers , Microscopy/instrumentation , Microscopy/methods , Optical Imaging/instrumentation , Patch-Clamp Techniques/instrumentation , Photolysis , Synaptic Transmission
SELECTION OF CITATIONS
SEARCH DETAIL
...